Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)
This study has been completed.
Study NCT00000623 Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received: October 27, 1999 Last Updated: November 29, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anemia, Cooley's
Beta-Thalassemia
Hematologic Diseases
Thalassemia
Osteoporosis
Iron Overload
Hypertension, Pulmonary
Additional conditions recognized in this trial
Anemia
Hypertension
More general conditions related to this trial
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Bone Diseases
Bone Diseases, Metabolic
Cardiovascular Diseases
Genetic Diseases, Inborn
Hemoglobinopathies
Iron Metabolism Disorders
Lung Diseases
Metabolic Diseases
Musculoskeletal Diseases
Respiratory Tract Diseases
Vascular Diseases
Interventions listed in this trial
Deferoxamine
Deferiprone
Arginine
Sildenafil
Decitabine
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Cardiovascular Agents
Chelating Agents
Enzyme Inhibitors
Iron Chelating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Phosphodiesterase Inhibitors
Siderophores
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)
Thalassemia Clinical Research Network
Back to top of Main Content
